HIV pronucleotide (Montpellier University)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameHIV pronucleotide (Montpellier University)
Drug Alias NameAZT prodrugs (Montpellier)Anti-HIV (Montpellier)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionReverse transcriptase inhibitors
TargetsReverse transcriptase
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity of Montpellier
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity of Montpellier
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A